Corporate Banner
Satellite Banner
Chromatography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent to Host Forensics Webinar

Published: Wednesday, June 05, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
The webinar, which will be held on June 20, will focus on LC/MS/MS methods for cannabinoid and benzodiazepine quantitation in whole blood samples.

The new quantitative methods, designed to run on Agilent’s LC/MS/MS instrumentation, fulfill stringent validation guidelines and provide forensic toxicology laboratories with a complete protocol for the quantitation of two of the most commonly abused drug classes in the United States. This set of Agilent methods is the first in a series now under evaluation by the Virginia Department of Forensic Science. Additional methods will cover 150 commonly abused drugs, spanning more than 10 classes of drugs, including designer drugs, for use in forensic toxicology.

During the webinar, Dr. Rebecca Wagner, research analyst from Virginia’s Department of Forensic Science, will describe the methods and their applications in detail. Attendees will receive electronic access to the complete set of standard operating procedures, detailed validation data, and the LC/MS/MS method to help their laboratories implement the methodology. The webinar will also be available for on-demand replay.

“One of the greatest challenges laboratories face when onboarding new technology is method development and validation,” said Tom Gluodenis, Agilent’s global marketing manager of forensics and toxicology. “That’s why we have collaborated with lab director Linda Jackson and her team at the Virginia Department of Forensic Science to develop a set of standardized LC/MS/MS methods for law enforcement’s most commonly tested drugs. This set of panels will enable forensic toxicology laboratories to obtain immediate, high-quality results with minimal effort.”

“We have developed two separate quantitative methods for the analysis of cannabinoids, benzodiazepines and their metabolites,” said Dr. Wagner. “These standardized methods meet rigorous validation guidelines, including those proposed by the Scientific Working Group for Forensic Toxicology. They take the onus off toxicologists to develop their own quantitative methods, and provide them with thoroughly validated methods for some of their most commonly analyzed compounds.”

“Now, when laboratories purchase Agilent LC/MS/MS instrumentation,” Gluodenis said, “we can provide them with both highly reliable technology and a set of advanced screening solutions that have been validated by one of the nation’s preeminent forensic institutions.”

Method Development

The Virginia Department of Forensic Science analyzes biological specimens for the presence or absence of drugs and alcohol in DUI/DUID, medical examiner, and police cases. Cannabinoids and benzodiazepines are two of the more frequently quantitated drug classes for DUID cases in the Commonwealth of Virginia. In 2012, 2,524 DUID cases were analyzed. Of those cases, 35 percent contained cannabinoids and 31 percent contained benzodiazepines.

Two separate quantitative methods have been developed and validated that include, but are not limited to, the experiments described in the method-validation guidelines proposed by the Scientific Working Group for Forensic Toxicology. The cannabinoid method targets were THC, THC-COOH, THC-OH, cannabinol and cannabidiol. There were 22 target compounds for the benzodiazepine method that included parent compounds and their metabolites. The department’s validation procedures, in conjunction with the proposed SWGTOX guidelines, have facilitated the implementation of a standard method development and validation plan. In the live webinar presentation on June 20, the methods will be described in detail, from initial development to implementation in the four laboratories that comprise the Virginia Department of Forensic Science.

Click below to register for the webinar, “LC/MS/MS Validation of a Cannabinoid and Benzodiazepine Method with Comparison to the Proposed SWGTOX Method Validation Standards.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent, Seoul National University to Collaborate on New Research Center
The facility will support new drug development center in the university's college of pharmacy.
Tuesday, May 13, 2014
Agilent Combines Its Life Sciences and Diagnostics Businesses
Decision follows Agilent's announcement that it plans to separate the company into two independent publicly traded companies.
Thursday, September 19, 2013
Agilent to Acquire Assets from ABC Instrumentación Analítica
The companies have signed a definitive agreement for Agilent to acquire assets from the privately held Mexican distributor.
Thursday, September 05, 2013
Agilent Reports Third-Quarter Results
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Thursday, August 15, 2013
Agilent Technologies Reports Fourth-Quarter 2012 Results
Revenues for the fourth fiscal quarter ended October 31, 2012 were $1.77 billion, up 2 percent one year ago.
Tuesday, November 20, 2012
Scientific News
Portable Kit Can Recover Traces of Chemical Evidence
A chemist at the National Institute of Standards and Technology (NIST) has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.
Diagnosis of Two Rare Childhood Diseases Improved
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
Artemisinin Mechanism Uncovered
New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria.
Cleaning Out the Membrane Each Day
Cell membranes are made up of a lipid bilayer that is constantly changing due to the flux of material in and out of the cell.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Novel Approach to Understanding Brain Function
Russell Poldrack scanned his brain to create the most detailed map of brain connectivity ever.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!